These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 376388)

  • 1. Effect of OK-432 on immunization with mitomycin-C-treated L1210 cells.
    Ryoyama K; Murayama T; Koshimura S
    Gan; 1979 Feb; 70(1):75-82. PubMed ID: 376388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432.
    Kataoka T; Oh-hashi F; Sakurai Y
    Cancer Res; 1979 Jul; 39(7 Pt 1):2807-10. PubMed ID: 445486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
    Ohno R; Kodera Y; Ogura M; Yamada H
    Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antileukemic effect in combination of 5-fluorouracil and OK-432.
    Koshimura S; Ryoyama K
    Cancer Treat Rep; 1977; 61(1):17-27. PubMed ID: 324619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between low-dose chemotherapy and immunotherapy in mouse L1210 leukemia.
    Relyveld EH; Bizzini B; Ophir R; Ben-Efraim S
    Cancer Treat Rep; 1987 Mar; 71(3):241-6. PubMed ID: 3102055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A.
    Kataoka T; Oh-Hashi F; Sakurai Y
    Gan; 1982 Apr; 73(2):193-205. PubMed ID: 6811360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local injection of OK-432 and mitomycin C into vulvar cancer responding poorly to bleomycin and linac irradiation].
    Yakabe A; Yamashita S; Kinashi N; Ito T
    Nihon Gan Chiryo Gakkai Shi; 1987 May; 22(4):758-62. PubMed ID: 2444661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 9. Effect of the mitomycin C-treated, cryopreserved immune reaction combined with biological response modifier, OK-432].
    Ogawa Y; Maeda T; Yoshida S; Yamamoto Y; Morita M; Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):946-50. PubMed ID: 6413627
    [No Abstract]   [Full Text] [Related]  

  • 11. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
    Kataoka T; Yamamoto T; Honjo K; Murayama T
    Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mode of action of BCG.
    Mitchell MS; Kirkpatrick D; Mokyr MB; Gery I
    Nat New Biol; 1973 Jun; 243(128):216-8. PubMed ID: 4197570
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro production of immune interferon (IFN gamma) by murine spleen cells when different sensitizing antigens are used in vivo and in vitro.
    Saito M; Yamaguchi T; Ebina T; Koi M; Aonuma E; Usami H; Ishida N
    Cell Immunol; 1983 Jun; 78(2):379-86. PubMed ID: 6407761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Micrococcus, BCG and related polysaccharides in the specific and non-specific immune resistance to murine L1210 leukemia [proceedings].
    Verloes R; Atassi G; Dumont P; Kanarek L
    Arch Int Physiol Biochim; 1978 May; 86(2):466-8. PubMed ID: 81034
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of immunochemotheray on advanced gastric cancer--combination of OK-432 (picibanil), mitomycin C, and 5-fluorouracil (MF-O therapy) (author's transl)].
    Nio Y; Nakamoto K; Tanaka A; Kikuchi S; Henmi K
    Nihon Gan Chiryo Gakkai Shi; 1980 Apr; 15(2):161-5. PubMed ID: 7400644
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. Suppression of generation of effector cells for pancreatic B cell destruction.
    Shintani S; Satoh J; Seino H; Goto Y; Toyota T
    J Immunol; 1990 Jan; 144(1):136-41. PubMed ID: 2295787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice.
    Kai S; Tanaka J; Nomoto K; Torisu M
    Clin Exp Immunol; 1979 Jul; 37(1):98-105. PubMed ID: 314874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
    Hattori H; Mikuriya S; Mamiya T; Hatano K; Shiina T; Yamada T
    Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy with neuraminidase-treated cells and bacillus Calmette-Guerin.
    Kollmorgen GM; Killion JJ; Sansing WA; Cantrell JL; Bundren JC; LeFever AV
    Surgery; 1976 Feb; 79(02):202-8. PubMed ID: 1108258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.